Advanced imaging studies further reveal that patients with TD exhibit increased dopamine transporter (DAT) binding and reduced serotonin levels, underscoring the importance of neurotransmitter imbalance in disease progression (5). Here, SLC6A3 is linked to thanatophoric dysplasia.